Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBT Validation in Emricasan NASH Study
NCT03439189Phase 2Completed
- Sponsor
- Meridian Bioscience
- Start
- Aug 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emricasan in Nonalcoholic steatohepatitis (NASH), Liver cirrhosis (LC), Portal Hypertension (PH), sponsored by Meridian Bioscience. Started Aug 2016; status: completed.
02
Drugs
emricasan
03
Conditions
Nonalcoholic steatohepatitis (NASH)Liver cirrhosis (LC)Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT03439189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03439189.